ACTIVE

ESKA PHARMA

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

57 k €

+213.5% YoY

Gross margin

115,4 k €

+23.8% YoY

Equity

584,7 k €

+10.8% YoY

What does ESKA PHARMA do?

ESKA PHARMA is a Private company with limited liability incorporated in 2011. Its main activity is: Management consultancy activities. Its registered office is in Bruxelles.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0840.007.528

Incorporation

06/10/2011

Legal form

Private company with limited liability

Registered office

Rue Antoine Dansaert 1
1000 Bruxelles · BruxellesSee on map

Contributed capital

12 400,00 €

Latest accounts

31/12/2024

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities

Signals

ProfitableSolid equityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 13 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012
Income statement
Gross margin	115,4 k €	+23.8%	93,3 k €	-66.9%	281,9 k €	+286%	73 k €	+18.9%	61,4 k €	-32.4%	90,8 k €	+9.9%	82,6 k €	-5.3%	87,2 k €	-17.2%	105,3 k €	-6.5%	112,7 k €	+17.4%	96 k €	-32.2%	141,6 k €	+9.9%	128,8 k €
EBITDA	111,4 k €	+26.4%	88,2 k €	-68.6%	281,1 k €	+295%	71,2 k €	+26.8%	56,1 k €	+1213%	-5 k €	-106%	80,6 k €	-4.6%	84,4 k €	-17.7%	102,6 k €	-7.1%	110,4 k €	+24.2%	88,9 k €	-36.9%	140,9 k €	+10.0%	128 k €
Operating result	96,3 k €	+31.8%	73 k €	-72.5%	265,9 k €	+375%	56 k €	+36.7%	41 k €	+303%	-20,2 k €	-131%	64,7 k €	-5.6%	68,6 k €	-20.9%	86,7 k €	-8.3%	94,6 k €	+29.5%	73 k €	-48.1%	140,9 k €	+10.0%	128 k €
Net result	57 k €	+214%	18,2 k €	-91.5%	213,2 k €	+283%	55,7 k €	+1300%	4 k €	+109%	-46,5 k €	-245%	32,1 k €	+21.6%	26,4 k €	-30.9%	38,2 k €	-12.4%	43,6 k €	+88.9%	23,1 k €	-68.8%	73,9 k €	+22.7%	60,2 k €
Balance sheet
Equity	584,7 k €	+10.8%	527,8 k €	+3.6%	509,6 k €	+57.9%	322,8 k €	+20.8%	267,1 k €	+1.5%	263,2 k €	-15.0%	309,7 k €	+11.5%	277,6 k €	+10.5%	251,3 k €	+17.9%	213,1 k €	+25.7%	169,5 k €	+15.7%	146,5 k €	+102%	72,6 k €
Total assets	1,6 M €	-2.7%	1,7 M €	+0.7%	1,6 M €	-8.4%	1,8 M €	+4.5%	1,7 M €	-0.3%	1,7 M €	+79.2%	962,4 k €	-3.6%	998,2 k €	-1.2%	1 M €	-3.7%	1 M €	-2.0%	1,1 M €	+5.2%	1 M €	+3.3%	984,8 k €
Cash	715,8 €	-93.6%	11,1 k €	+188%	3,9 k €	+518%	624,5 €	-59.0%	1,5 k €	-78.2%	7 k €	+135%	3 k €	-24.7%	4 k €	+33.8%	3 k €	-60.3%	7,4 k €	-73.6%	28,1 k €	+189%	9,7 k €	+24.3%	7,8 k €
Debts	1 M €	-9.0%	1,1 M €	-0.6%	1,1 M €	-22.9%	1,5 M €	+3.7%	1,4 M €	-2.6%	1,5 M €	+126%	647,3 k €	-10.0%	719,5 k €	-4.8%	755,6 k €	-9.4%	833,8 k €	-7.2%	898,6 k €	+3.4%	869,2 k €	-4.4%	909,7 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 4 ended

Active mandates

Samia El Ouardani

Mandate

Active

Ended mandates

SAMIA EL OUARDANI

Manager · since 06 octobre 2011

Ended

Samia El Ouardani

Director

Ended

Samia El Quardani

Autre fonction

Ended

Samia El Quardani

Director

Ended

At this address

Other companies at this address

Company	CBE no.
SANDRA● Active	0473.291.506
Uniphar● Active	0403.095.079

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Micro model	Micro model	Micro model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/10/2025	29/10/2024	31/10/2023	16/01/2023	29/10/2021	24/11/2020
General meeting	28/10/2025	24/06/2024	26/06/2023	31/08/2022	31/08/2021	31/08/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

13 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2024	28/10/2025	28/10/2025	French	PDF
Micro model	31/12/2023	24/06/2024	29/10/2024	French	PDF
Micro model	31/12/2022	26/06/2023	31/10/2023	French	PDF
Abridged model	31/12/2021	31/08/2022	16/01/2023	French	PDF
Abridged model	31/12/2020	31/08/2021	29/10/2021	French	PDF
Abridged model	31/12/2019	31/08/2020	24/11/2020	French	PDF
Abridged model	31/12/2018	25/05/2019	25/07/2019	French	PDF
Abridged model	31/12/2017	26/05/2018	03/07/2018	French	PDF
Abridged model	31/12/2016	27/05/2017	20/06/2017	French	PDF
Abridged model	31/12/2015	28/05/2016	17/06/2016	French	PDF
Abridged model	31/12/2014	23/05/2015	06/07/2015	French	PDF
Abridged model	31/12/2013	24/05/2014	27/06/2014	French	PDF
Abridged model	31/12/2012	25/05/2013	27/08/2013	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 1 active · 4 ended

Active mandates

Samia El Ouardani

Mandate

Active

Ended mandates

SAMIA EL OUARDANI

Manager · since 06 octobre 2011

Ended

Samia El Ouardani

Director

Ended

Samia El Quardani

Autre fonction

Ended

Samia El Quardani

Director

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other18/10/2011
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 202457 k €↑
2023
Annual accounts 202318,2 k €↓
2022
Annual accounts 2022213,2 k €↑
2021
Annual accounts 202155,7 k €↑
2020
Annual accounts 20204 k €↑
2019
Annual accounts 2019-46,5 k €↓
2018
Annual accounts 201832,1 k €↑
2017
Annual accounts 201726,4 k €↓
2016
Annual accounts 201638,2 k €↓
2015
Annual accounts 201543,6 k €↑
2014
Annual accounts 201423,1 k €↓
2013
Annual accounts 201373,9 k €↑
2012
Annual accounts 201260,2 k €
06/10/2011
IncorporationPrivate company with limited liability

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

ESKA PHARMA

Overview

What does ESKA PHARMA do?

Trend over 13 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline